The new GENEROUS Model is intended to align Medicaid prescription prices with global standards. The Centers for Medicare & Medicaid Services (CMS) introduced a pilot program, the GENEROUS…
Read MorePrescription Drugs
FDA Drafts New Guidance for the Development of Affordable Biosimilar Drugs
The new guidance seeks to lower development costs and improve patient access to safe, effective alternatives to high-cost biologic medicines. The U.S. Food and Drug Administration (FDA) recently…
Read More
President Announces Obesity Drug Deal with Pharmaceutical Companies
The most recent development would greatly reduce the cost under the president’s Most Favored Nation prescription drug pricing policy. President Donald Trump announced that a deal has been…
Read More
President Announces TrumpRx Medication Program
He stated that purchasing from manufacturers directly will reduce prices. President Donald Trump announced a new program called TrumpRx this week under his Most Favored Nation (MFN) initiative,…
Read More
President Trump Plans New Tariffs for Several Industries
The president highlights the compromising of national security by foreign trade practices and the need to protect U.S. manufacturing from “unfair outside competition.“ President Donald Trump announced a…
Read MoreHHS and FDA to Require Full Safety Disclosures in Drug Ads
Secretary Kennedy denounces pharmaceutical ads but does not advocate for ban. The Food and Drug Administration (FDA) began the process last week of rescinding a 1997 policy that…
Read More
FDA Begins Daily Updates of Adverse Drug Event Reports
The new reporting schedule is intended to improve transparency and speed in detecting safety concerns. The Food and Drug Administration has started publishing daily updates from the FDA…
Read MoreFDA Updates Opioid Labels to Emphasize Long-Term Risks
New labeling rules follow evidence linking extended opioid use to serious health dangers, including addiction and overdose. The U.S. Food and Drug Administration (FDA) has mandated updated safety…
Read More
President Calls on Drug Makers to Reduce Prices Within 60 Days
Nearly half of prescription prices rose higher than the rate of inflation between 2022 and 2023. President Donald Trump sent letters to over a dozen pharmaceutical companies at…
Read More
Federal Agencies Request Public Input on Healthcare Price Transparency
The effort aligns with President Trump’s executive order on healthcare pricing. The Departments of Labor, Health and Human Services (HHS), and the Treasury recently issued a joint Request…
Read More